| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ablation of liver Fxr results in an increased colonic mucus barrier in mice
|
Ijssennagger, Noortje
|
|
|
3 |
5 |
p.
|
article
|
| 2 |
ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
|
Demirtas, Coskun O.
|
|
|
3 |
5 |
p.
|
article
|
| 3 |
Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease
|
Masyuk, Tatyana
|
|
|
3 |
5 |
p.
|
article
|
| 4 |
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication ⋆
|
Israelsen, Mads
|
|
|
3 |
5 |
p.
|
article
|
| 5 |
Contents
|
|
|
|
3 |
5 |
p.
|
article
|
| 6 |
Copyright and information
|
|
|
|
3 |
5 |
p.
|
article
|
| 7 |
Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
|
Torp, Nikolaj
|
|
|
3 |
5 |
p.
|
article
|
| 8 |
Editorial Board page
|
|
|
|
3 |
5 |
p.
|
article
|
| 9 |
Estimating the clinical prevalence of Wilson’s disease in the UK
|
Wijayasiri, Pramudi
|
|
|
3 |
5 |
p.
|
article
|
| 10 |
Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production
|
Lucifora, Julie
|
|
|
3 |
5 |
p.
|
article
|
| 11 |
Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO2 spectrum
|
Kadry, Zakiyah
|
|
|
3 |
5 |
p.
|
article
|
| 12 |
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
|
Åström, Hanne
|
|
|
3 |
5 |
p.
|
article
|
| 13 |
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
|
Fossdal, Guri
|
|
|
3 |
5 |
p.
|
article
|
| 14 |
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
|
Degroote, Helena
|
|
|
3 |
5 |
p.
|
article
|
| 15 |
Introduction to corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
|
Torp, Nikolaj
|
|
|
3 |
5 |
p.
|
article
|
| 16 |
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
|
van Kleef, Laurens A.
|
|
|
3 |
5 |
p.
|
article
|
| 17 |
Non-alcoholic fatty liver disease: A patient guideline
|
Francque, Sven M.
|
|
|
3 |
5 |
p.
|
article
|
| 18 |
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
|
Praktiknjo, Michael
|
|
|
3 |
5 |
p.
|
article
|
| 19 |
The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites
|
Mansour, Sohaïb
|
|
|
3 |
5 |
p.
|
article
|
| 20 |
The neurogliovascular unit in hepatic encephalopathy
|
Claeys, Wouter
|
|
|
3 |
5 |
p.
|
article
|
| 21 |
The role of cGAS-STING signalling in liver diseases
|
Chen, Ruihan
|
|
|
3 |
5 |
p.
|
article
|
Journal description